Syridex Bio Selected by NJEDA

Life sciences impact investment firm receives allocation to support businesses advancing health equity, targeting therapies for diseases that disproportionately affect underserved populations. NEW YORK–(BUSINESS WIRE)–Syridex Bio (“Syridex”), an impact-driven, life…
Read More
Menu